Evidence map›Paper›PMID 37430367›Full record

ArticleAnnals of clinical microbiology and antimicrobials2023

Metagenomic next-generation sequencing for rapid detection of pulmonary infection in patients with acquired immunodeficiency syndrome.

Juan Zhong, Yanfen Liu, Na Luo, Qiu Wei, Qisi Su, Jun Zou, Xiaozhong Wu, Xianzhen Huang, Yuting Jiang, Lijuan Liang and 2 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical microbiology and antimicrobials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Juan Zhong *Department of Traditional Chinese Medicine, The First People's Hospital of Nanning, Nanning, China. syzj0059@126.com.
Yanfen Liu *The Fourth People's Hospital of Nanning, Nanning, China.
Na Luo *NanNing Center for Disease Control and Prevention, Nanning, China.
Qiu WeiDepartment of Traditional Chinese Medicine, The First People's Hospital of Nanning, Nanning, China.
Qisi SuThe Fourth People's Hospital of Nanning, Nanning, China.
Jun ZouThe Fourth People's Hospital of Nanning, Nanning, China.
Xiaozhong WuDepartment of Traditional Chinese Medicine, The First People's Hospital of Nanning, Nanning, China.
Xianzhen HuangThe Fourth People's Hospital of Nanning, Nanning, China.
Yuting JiangDepartment of Traditional Chinese Medicine, The First People's Hospital of Nanning, Nanning, China.
Lijuan LiangNanning Yunju Biotechnology Co., Ltd, Nanning, China.
Hongmian LiThe People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China. 18022081568@163.com.
Jianyan LinThe First People's Hospital of Nanning, Nanning, China. linjianyan@126.com.
First People's Hospital of Nanning · CNThe Fourth People's Hospital · CNGuangxi Center for Disease Prevention and Control · CNThe People's Hospital of Guangxi Zhuang Autonomous Region · CN

Funding

the Science and Technology Planning Project of Nanning City 20203052the Youth Science and Technology Talents Cultivation Project of Nanning RC20180103
6 · The paper itself

Abstract

backgroundAcquired immunodeficiency syndrome (AIDS) is associated with a high rate of pulmonary infections (bacteria, fungi, and viruses). To overcome the low sensitivity and long turnaround time of traditional laboratory-based diagnostic strategies, we adopted metagenomic next-generation sequencing (mNGS) technology to identify and classify pathogens.

resultsThis study enrolled 75 patients with AIDS and suspected pulmonary infections who were admitted to Nanning Fourth People's Hospital. Specimens were collected for traditional microbiological testing and mNGS-based diagnosis. The diagnostic yields of the two methods were compared to evaluate the diagnostic value (detection rate and turn around time) of mNGS for infections with unknown causative agent. Accordingly, 22 cases (29.3%) had a positive culture and 70 (93.3%) had positive valve mNGS results (P value < 0.0001, Chi-square test). Meanwhile, 15 patients with AIDS showed concordant results between the culture and mNGS, whereas only one 1 patient showed concordant results between Giemsa-stained smear screening and mNGS. In addition, mNGS identified multiple microbial infections (at least three pathogens) in almost 60.0% of patients with AIDS. More importantly, mNGS was able to detect a large variety of pathogens from patient tissue displaying potential infection and colonization, while culture results remained negative. There were 18 members of pathogens which were consistently detected in patients with and without AIDS.

conclusionsIn conclusion, mNGS analysis provides fast and precise pathogen detection and identification, contributing substantially to the accurate diagnosis, real-time monitoring, and treatment appropriateness of pulmonary infection in patients with AIDS.

Indexed as

Acquired Immunodeficiency SyndromePneumoniaAzure StainsHigh-Throughput Nucleotide SequencingHospitalizationHospitalsHumansAzure StainsAcquired immunodeficiency syndromeDiagnosisMetagenomic next-generation sequencingPulmonary infection

Identifiers

PMID37430367
PMCPMC10334547
OpenAlexW4383823157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.